Eugene Woodruff - Cascade
Cascade Chemistry announced in February 2021, while still independent, that it would break ground on a new facility in Woodruff, OR, 10 miles from their base facility in Eugene. The facility is expected to be operational in 2022.
The 28,000-square-foot building currently under construction will initially include five suites for Phase 1 and Phase 2 cGMP manufacturing with flow hydrogenation and reactors up to 400 liters. Additional capacity for API Phase 3 and commercial scale cGMP manufacturing up to 1,000 liters will be added in 2022. The second building, with 7,000 square feet, is reserved for future expansion.
Quality Assurance and Quality Control:
The quality systems for Woodruff will mirror those of our Eugene Polk facility.
It is our philosophy that quality is the key component for successful cGMP manufacturing, so our quality system exceeds what is required by the FDA for the manufacture of pharmaceutical products. We understand that quality is not simply a component which is applied to a product after processing, but rather quality is a guiding virtue by which compliance is built into a product through due diligence at each step of a process. Allow our problem solvers to customer craft a process solution which meets your needs and quality requirements